BGU researchers are on the verge of a breakthrough that is bringing the world closer to a cure for diabetes.
Researchers at BGU’s Clinical Islet Laboratory are pursuing three major goals: transplants and new drugs, gene therapy, and the creation of a “transgenic” mouse that can tolerate human material for experimentation. They’re working on new drugs based on the alpha-1-antitrypsin (AAT) protein that reduces inflammation. Recent clinical trials demonstrated that infusion of AAT in recently diagnosed type 1 diabetes patients could eventually eliminate the need for insulin injections. A new clinical trial is under way to evaluate AAT dosing levels and duration.
Diabetes Videossee all videos
Diabetes Newssee all news
Wine Has Demonstrable Benefits for Type 2 Diabetes
A two-year BGU study shows moderate wine consumption can raise good cholesterol while lowering the bad.
Curing Diabetes: An Interview with Dr. Eli Lewis
Dr. Lewis discusses how he could be the person who cures diabetes once and for all.
Diabetic Foot Is Linked to Cognitive Deterioration
Dr. Rachel Natovich discovers this diabetes symptom can be an indicator of more severe complications.